HNRNPA1 and leukemia: The study of Gao and colleagues demonstrated that HNRNPA1 (a type of RNA-binding proteins) -mediated exosomal transfer of miR-320 from leukemia cells to BMMSC is an important process of leukemia progression and could be a potential therapeutic target for CML.